Avail Medsystems, which develops telemedicine software to let surgical teams in operating rooms collaborate with remote medical experts, raises $100M Series B
Christine Hall / Crunchbase News :
Context & Ripple Effects
Avail Medsystems' $100M Series B is the largest check yet in a cluster of funding rounds aimed at wiring the operating room for remote participation. Activ Surgical had raised just $15M three months earlier, bringing its total to $32M, while [[a:965652|Proximie pulled in $38M for AI-based AR tech that lets surgeons interact virtually during procedures]].
The gap matters: Avail's raise is more than double what its closest funded peers have attracted combined at the Series B stage, giving it the deepest war chest among companies building software layers over surgery. Later entrants like Medivis, which raised a $20M Series A for holographic MRI and CT rendering, show the category broadening from collaboration into visualization.
First-order effects
- Avail gains the capital to scale hospital deployments of its remote-expert collaboration software, while direct rivals Proximie and Activ Surgical now compete against a far better-funded player for the same OR accounts.
Second-order effects
- Hospitals evaluating remote surgical support face a consolidating vendor set, pushing competitors toward differentiation — Activ Surgical's hardware-agnostic approach and Proximie's AR angle become their answers to Avail's scale.
Third-order effects
- If the funding cadence holds, the operating room becomes a networked platform where remote expertise is a purchasable service layer, and the winners will be whoever owns the software connection between the OR table and outside specialists.
The trend: Capital is consolidating around connected-surgery software, turning the operating room into the next major telehealth battleground after general app-based care.